{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-055182","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2025-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.153533+00:00","generated_at":"2026-05-19T05:10:53.615945+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Citius Oncology nearing commercial launch of LYMPHIR for CTCL in H2 2025","bullets":["Commercial-scale manufacturing completed; inventory sufficient for 12-18 months post-launch with 60-month shelf life.","70 institutional oncology centers already registered via the LYMPHIR website.","LYMPHIR included in NCCN guidelines; assigned permanent J-code for reimbursement.","Parent Citius Pharma's recent capital raise supports final launch preparations.","Strategic partnership discussions underway with financial advisor to expand market reach."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-055182","json":"https://secwatch.observer/filing/0001213900-25-055182.json","markdown":"https://secwatch.observer/filing/0001213900-25-055182.md","text":"https://secwatch.observer/filing/0001213900-25-055182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025055182/0001213900-25-055182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025055182/ea0245933-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T05:10:53.615945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}